Safety Study of Salmeterol in Asthma in Adults

Tom Wilsdon; Ganessan Kichenadasse; Andrew Rowland

doi:10.1056/NEJMc1608323

Safety Study of Salmeterol in Asthma in Adults

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Abstract

The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...

Original language	English
Pages (from-to)	1096-1097
Number of pages	2
Journal	New England Journal of Medicine
Volume	375
Issue number	11
DOIs	https://doi.org/10.1056/NEJMc1608323
Publication status	Published - 15 Sept 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Asthma
Salmeterol
long-acting beta-agonist (LABA)

Access to Document

10.1056/NEJMc1608323Licence: In Copyright

Cite this

@article{830e6b72fb854ba290856e8535b2eaa2,

title = "Safety Study of Salmeterol in Asthma in Adults",

abstract = "The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...",

keywords = "Asthma, Salmeterol, long-acting beta-agonist (LABA)",

author = "Tom Wilsdon and Ganessan Kichenadasse and Andrew Rowland",

year = "2016",

month = sep,

day = "15",

doi = "10.1056/NEJMc1608323",

language = "English",

volume = "375",

pages = "1096--1097",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

TY - JOUR

T1 - Safety Study of Salmeterol in Asthma in Adults

AU - Wilsdon, Tom

AU - Kichenadasse, Ganessan

AU - Rowland, Andrew

PY - 2016/9/15

Y1 - 2016/9/15

N2 - The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...

AB - The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...

KW - Asthma

KW - Salmeterol

KW - long-acting beta-agonist (LABA)

UR - https://www.scopus.com/pages/publications/84988320455

U2 - 10.1056/NEJMc1608323

DO - 10.1056/NEJMc1608323

M3 - Letter

SN - 0028-4793

VL - 375

SP - 1096

EP - 1097

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 11

ER -

Safety Study of Salmeterol in Asthma in Adults

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this